Acquisition Growth Currier has recently expanded through strategic acquisitions including Springboard Manufacturing and MOS Plastics, signaling aggressive growth and a broader capability footprint in medical contract manufacturing. This creates cross-sell opportunities to integrate customers of the acquired entities and to offer expanded services such as end-to-end design, molding, assembly, and sterilization to a larger client base.

Board Leadership New additions to the Board of Directors in early 2026 indicate a shift in governance and strategy, potentially aligning Currier with growth mandates and more rigorous oversight. This can present an opening to engage C-suite stakeholders around strategic partnerships, capital-intensive programs, and long-term manufacturing commitments.

Healthcare Focus Currier’s emphasis on medical devices, diagnostics, drug delivery, and life sciences, coupled with ISO 8 and ISO 7 cleanroom capabilities, positions the company as a strong partner for regulated, high-precision components. There are clear upsell opportunities for customers pursuing scalable manufacturing, complex molding, sterilization, and post-molding services in minimally invasive and biologics-related therapies.

Scale and Capabilities With a revenue range of 50 to 100 million and a full spectrum of services from design for manufacturability to kitting and sterilization management, Currier is well-suited to capture programs at scale. Prospects in need of rapid speed-to-market and regulated manufacturing processes can be approached for long-running production lines and platform programs.

Leadership for Growth Sheridan Capital’s ownership and the appointment of new CEO and board members signal a growth-oriented investment thesis. This creates a narrative to engage potential customers seeking stable, venture-backed partners with capital for capacity expansion, capital equipment upgrades, and qualification of new products.